Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2018-11-14 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
2018年第四次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, agenda, and voting results of Shenzhen BGI Genomics Co., Ltd.'s 2018 fourth extraordinary general meeting of shareholders. It details the legality and compliance of the meeting with relevant laws and company rules. The document is not a financial report, earnings release, or management discussion, but rather a legal opinion on the shareholder meeting and its resolutions. It includes detailed voting results and procedural validation, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5946 characters, which is substantive and not a mere announcement or report publication notice. Therefore, the best fitting classification is DVA.
2018-11-14 Chinese
关于持股5%以上股东减持股份比例达到1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding a shareholder holding more than 5% reducing their shareholding by 1%. It details the shareholder's name, the number of shares reduced, the method of reduction, and compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds.
2018-11-14 Chinese
关于召开2018年第四次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2018 fourth extraordinary general meeting of shareholders for Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on, registration details, and proxy voting instructions. The document does not contain financial statements, audit results, or earnings data. It is not a report of voting results but a notice and instructions for the upcoming shareholder meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2018-11-12 Chinese
关于增加2018年度预计日常关联交易额度的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding an increase in the 2018 estimated daily related-party transaction amount. It details the background, reasons, and approvals related to increasing the transaction limits with related parties for purchasing sequencing equipment. The document includes references to board meetings, independent directors' opinions, supervisory board reviews, and sponsor institution verification. It is a regulatory announcement about a corporate governance and related-party transaction matter, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but focuses on disclosure of related-party transaction changes and approvals. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about related-party transactions and corporate governance compliance.
2018-11-01 Chinese
独立董事关于第二届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding a specific board meeting matter about increasing the 2018 estimated daily related-party transaction limit. It references compliance with stock exchange listing rules and company bylaws. The content is focused on board/management governance and approval of a corporate transaction, not a full financial report or earnings release. The document length is short (537 characters) and it is a formal opinion related to board decisions, fitting the category of Board/Management Information (MANG).
2018-11-01 Chinese
关于2018年第四次临时股东大会增加临时提案暨股东大会补充通知的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement regarding the addition of a temporary proposal to the agenda of the 2018 fourth extraordinary shareholders' meeting of Shenzhen BGI Genomics Co., Ltd. It details the meeting's date, voting procedures, eligibility, and other administrative information related to the shareholders' meeting. It does not contain financial statements, audit results, or detailed management discussion. It is not a report itself but an official notice about the shareholders' meeting and its agenda changes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is about notifying shareholders of the meeting agenda and voting procedures rather than soliciting proxies or providing detailed information statements, it is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-11-01 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.